股本结构

单位:万股
公告日期 2024-05-06 2024-05-06 2024-02-26 2024-02-26 2023-11-06 2023-11-06
证券总股本 3754.35 3750.77 3739.68 3699.07 3689.68 3688.22
普通股本 3754.35 3750.77 3739.68 3699.07 3689.68 3688.22
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2024-05-01 2024-03-31 2024-02-21 2023-12-31 2023-11-01 2023-09-30
注释:中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本(万股) 变动后优先股(万股) 变动原因 变动日期
2024-05-06 3754.35 未披露 定期报告 2024-05-01
2024-05-06 3750.77 未披露
更多>>
From December 31, 2023 to March 31, 2024 Exercise of stock options Issuance of common stock in connection with vesting of restricted stock units and performance share units Taxes withheld on net settled vesting of restricted stock units Issuance of common stock under employee stock purchase plan
2024-03-31
2024-02-26 3739.68 未披露 定期报告 2024-02-21
2024-02-26 3699.07 未披露
更多>>
From December 31, 2022 to December 31, 2023 Exercise of stock options Taxes withheld on net settled vesting of restricted stock units Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units
2023-12-31
2023-11-06 3689.68 未披露 定期报告 2023-11-01
2023-11-06 3688.22 未披露
更多>>
From June 30, 2023 to September 30, 2023 Exercise of stock options Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units Taxes withheld on net settled vesting of restricted stock units
2023-09-30
2023-08-07 3675.04 未披露 定期报告 2023-08-02
2023-05-08 3662.62 未披露 定期报告 2023-05-02
2023-04-21 3659.40 未披露 定期报告 2023-04-17
2023-05-08 3658.95 未披露
更多>>
From December 31, 2022 to March 31, 2023 Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units Exercise of stock options Taxes withheld on net settled vesting of restricted stock units
2023-03-31
2023-02-27 3649.54 未披露 定期报告 2023-02-22
2023-02-27 3623.55 未披露
更多>>
From December 31, 2021 to December 31, 2022 Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units Exercise of stock options Taxes withheld on net settled vesting of restricted stock units
2022-12-31
2022-11-07 3614.23 未披露 定期报告 2022-11-01
2022-11-07 3613.36 未披露
更多>>
From June 30, 2022 to September 30, 2022 Exercise of stock options Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units
2022-09-30
2022-08-08 3592.71 未披露 定期报告 2022-08-02
2022-08-08 3590.75 未披露
更多>>
From March 31, 2022 to June 30, 2022 Issuance of common stock in connection with vesting of restricted stock units Exercise of stock options
2022-06-30
2022-05-09 3579.19 未披露 定期报告 2022-05-03
2022-04-29 3578.54 未披露 定期报告 2022-04-25
2022-05-09 3572.44 未披露
更多>>
From December 31, 2021 to March 31, 2022 Exercise of stock options Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units Taxes withheld on net settled vesting of restricted stock units
2022-03-31
2022-02-25 3565.36 未披露 定期报告 2022-02-18
2022-02-25 3544.45 未披露
更多>>
From December 31, 2020 to December 31, 2021 Exercise of stock options Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units Restricted stock units withheld in net settlement for tax
2021-12-31
2021-11-08 3530.45 未披露 定期报告 2021-11-02
2021-11-08 3529.50 未披露
更多>>
From June 30, 2021 to September 30, 2021 Exercise of stock options Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units
2021-09-30
2021-08-09 3515.03 未披露 定期报告 2021-08-04
2021-08-09 3512.93 未披露
更多>>
From March 31, 2021 to June 30, 2021 Exercise of stock options Issuance of common stock in connection with vesting of restricted stock units Taxes withheld on net settled vesting of restricted stock units
2021-06-30
2021-05-10 3498.31 未披露 定期报告 2021-05-06
2021-04-29 3497.38 未披露 定期报告 2021-04-28
2021-05-10 3492.90 未披露
更多>>
From December 31, 2020 To March 31, 2021 Exercise of stock options Unrealized gain on available-for-sale securities Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units Taxes withheld on net settled vesting of restricted stock units
2021-03-31
2021-02-26 3484.27 未披露 定期报告 2021-02-22
2021-02-26 3468.43 未披露
更多>>
From December 31, 2019 to December 31, 2020 Exercise of stock options Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units Issuance of common stock in connection with public offering, net of issuance costs of $6.1 million Restricted stock units withheld in net settlement for tax
2020-12-31
2020-11-10 3425.98 未披露 定期报告 2020-11-03
2020-11-10 3423.62 未披露
更多>>
From June 30, 2020 to September 30, 2020 Exercise of stock options Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units Restricted stock units withheld in net settlement for tax
2020-09-30
2020-08-12 3400.29 未披露 定期报告 2020-08-06
2020-08-12 3394.56 未披露
更多>>
From March 31, 2020 to June 30, 2020 Exercise of stock options Issuance of common stock in connection with public offering, net of issuance costs of $6.1 million Issuance of common stock in connection with vesting of restricted stock units Restricted stock units withheld in net settlement for tax
2020-06-30
2020-06-19 3378.26 未披露
更多>>
On June 19, 2020, Shockwave Medical, Inc. (the “Company”) issued and sold an aggregate of 1,955,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), pursuant to an underwriting agreement dated June 16, 2020 (the “Underwriting Agreement”), among the Company and Morgan Stanley & Co. LLC and BofA Securities, Inc., as representatives of the several underwriters named therein (the “Underwriters”). The Shares include the full exercise of the Underwriters’ option to purchase an additional 255,000 shares of Common Stock pursuant to the Underwriting Agreement.
2020-06-19
2020-05-13 3186.03 未披露 定期报告 2020-05-06
2020-06-16 3186.16 未披露 定期报告 2020-04-30
2020-04-28 3186.22 未披露 定期报告 2020-04-27
2020-05-13 3182.76 未披露
更多>>
From December 31, 2019 to March 31, 2020 Exercise of stock options Issuance of common stock under employee stock purchase plan
2020-03-31
2020-03-12 3176.57 未披露 定期报告 2020-03-05
2020-03-12 3144.68 未披露
更多>>
From December 31, 2018 to December 31, 2019 Exercise of common stock warrants for cash Issuance of common stock upon net exercise of warrants Conversion of preferred stock to common stock upon initial public offering Issuance of common stock in connection with initial public offering, net of issuance costs of $11.5 million Issuance of common stock in connection with private placement Issuance of common stock in connection with public offering, net of issuance costs of $6.8 million Exercise of stock options Adjustment for fractional shares resulting from reverse stock split
2019-12-31
2019-11-19 3073.77 未披露 定期报告 2019-11-19
2019-11-08 2830.01 未披露 定期报告 2019-10-31
2019-11-08 2825.59 未披露
更多>>
from June 30, 2019 to September 30, 2019 Exercise of stock options
2019-09-30
2019-08-06 2802.69 未披露 定期报告 2019-08-01
2019-08-06 2802.37 未披露
更多>>
from March 31, 2019 to June 30,2019 Issuance of common stock upon net exercise of warrants Exercise of stock options
2019-06-30
2019-05-09 2801.24 未披露 定期报告 2019-05-01
2019-05-09 2787.09 1867.03 定期报告 2019-03-31
2019-03-08 2690.68 未披露
更多>>
1.Common stock offered 5,700,000 shares 2.The number of shares of common stock to be outstanding immediately after this offering is based upon 20,618,527 shares (including our convertible preferred stock on an as-converted basis and net exercise of certain outstanding warrants) outstanding as of December 31, 2018 3.A 12.2-for-one reverse stock split of our common stock and convertible preferred stock, which was effected on February 22, 2019
2019-03-07
2019-02-25 182.48 1867.03 定期报告 2018-12-31
From December 31, 2023 to March 31, 2024 Exercise of stock options Issuance of common stock in connection with vesting of restricted stock units and performance share units Taxes withheld on net settled vesting of restricted stock units Issuance of common stock under employee stock purchase plan
From December 31, 2022 to December 31, 2023 Exercise of stock options Taxes withheld on net settled vesting of restricted stock units Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units
From June 30, 2023 to September 30, 2023 Exercise of stock options Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units Taxes withheld on net settled vesting of restricted stock units
From December 31, 2022 to March 31, 2023 Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units Exercise of stock options Taxes withheld on net settled vesting of restricted stock units
From December 31, 2021 to December 31, 2022 Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units Exercise of stock options Taxes withheld on net settled vesting of restricted stock units
From June 30, 2022 to September 30, 2022 Exercise of stock options Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units
From March 31, 2022 to June 30, 2022 Issuance of common stock in connection with vesting of restricted stock units Exercise of stock options
From December 31, 2021 to March 31, 2022 Exercise of stock options Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units Taxes withheld on net settled vesting of restricted stock units
From December 31, 2020 to December 31, 2021 Exercise of stock options Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units Restricted stock units withheld in net settlement for tax
From June 30, 2021 to September 30, 2021 Exercise of stock options Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units
From March 31, 2021 to June 30, 2021 Exercise of stock options Issuance of common stock in connection with vesting of restricted stock units Taxes withheld on net settled vesting of restricted stock units
From December 31, 2020 To March 31, 2021 Exercise of stock options Unrealized gain on available-for-sale securities Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units Taxes withheld on net settled vesting of restricted stock units
From December 31, 2019 to December 31, 2020 Exercise of stock options Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units Issuance of common stock in connection with public offering, net of issuance costs of $6.1 million Restricted stock units withheld in net settlement for tax
From June 30, 2020 to September 30, 2020 Exercise of stock options Issuance of common stock under employee stock purchase plan Issuance of common stock in connection with vesting of restricted stock units Restricted stock units withheld in net settlement for tax
From March 31, 2020 to June 30, 2020 Exercise of stock options Issuance of common stock in connection with public offering, net of issuance costs of $6.1 million Issuance of common stock in connection with vesting of restricted stock units Restricted stock units withheld in net settlement for tax
On June 19, 2020, Shockwave Medical, Inc. (the “Company”) issued and sold an aggregate of 1,955,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), pursuant to an underwriting agreement dated June 16, 2020 (the “Underwriting Agreement”), among the Company and Morgan Stanley & Co. LLC and BofA Securities, Inc., as representatives of the several underwriters named therein (the “Underwriters”). The Shares include the full exercise of the Underwriters’ option to purchase an additional 255,000 shares of Common Stock pursuant to the Underwriting Agreement.
From December 31, 2019 to March 31, 2020 Exercise of stock options Issuance of common stock under employee stock purchase plan
From December 31, 2018 to December 31, 2019 Exercise of common stock warrants for cash Issuance of common stock upon net exercise of warrants Conversion of preferred stock to common stock upon initial public offering Issuance of common stock in connection with initial public offering, net of issuance costs of $11.5 million Issuance of common stock in connection with private placement Issuance of common stock in connection with public offering, net of issuance costs of $6.8 million Exercise of stock options Adjustment for fractional shares resulting from reverse stock split
from June 30, 2019 to September 30, 2019 Exercise of stock options
from March 31, 2019 to June 30,2019 Issuance of common stock upon net exercise of warrants Exercise of stock options
1.Common stock offered 5,700,000 shares 2.The number of shares of common stock to be outstanding immediately after this offering is based upon 20,618,527 shares (including our convertible preferred stock on an as-converted basis and net exercise of certain outstanding warrants) outstanding as of December 31, 2018 3.A 12.2-for-one reverse stock split of our common stock and convertible preferred stock, which was effected on February 22, 2019